EPISODE 18- From the JP Morgan Conference: The Impact of the Inflation Reduction Act

John was at the JP Morgan conference and is here to discuss the key takeaways of the Inflation Reduction Act: the small-molecule penalty, the value of small-molecule drugs, the importance of incentivizing post-approval research, intellectual property, and non-coverage decisions at CMS. You’ll also hear John’s take on the demand for a more pro-patient agenda.


Listen on Apple, Spotify, Google, YouTube, or your preferred podcast streaming platform.